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Background: The spontaneous onset of macroscopic arthropathy in the ankle of the particular F1 mice
descended from two Fas-deficient strains of mice; a mutant substrain of MRL/Mp.Faslpr (MRL/rpl) and
C3H/He.Faslpr (C3H/lpr) was recently observed.
Aim: To histopathologically characterise and genetically interpret the unique inheritance mode of disease
in this arthropathy model.
Methods: MRL/rpl, C3H/lpr, (MRL/rpl6C3H/lpr; MC) F1, (C3H/lpr6MRL/rpl; CM) F1 and MCF2 mice
were bred under specific pathogen-free conditions. Histopathological grade of arthropathy was
determined at 6 months by examination under a light microscope. To search for a linkage locus to the
arthropathy, the whole genome of selected 48 male MCF2 mice with 71 polymorphic microsatellite
markers was scanned, followed by quantitative trait locus analysis.
Results: The incidence of microscopically defined arthropathy in the male and female MCF1 groups was
100% and 19.4%, respectively. No incidence was observed in the parental strains, MRL/rpl and C3H/lpr,
and in CMF1 mice. In the MCF1 mice, the arthropathy mainly affected the ankle joints and was
histopathologically characterised by marked entheseal proliferation with chondrocytic differentiation and
ossification in the ankle joints, the manifestations similar to ankylosing enthesitis reported previously. An
MRL/rpl-derived autosomal dominant susceptibility locus was mapped in the distal of D7Mit68 (60 cM) to
the ankylosis onset.
Conclusion: The MCF1 mice stably develop spontaneous ankylosing disorders in the ankle, with a male
predominance. The unique inheritance mode of ankylosis is possibly interpreted by the genetic interaction
between the autosomal dominant locus and a Y-linked locus.
M
ultifactorial diseases develop under a proper genetic
condition with a particular environmental condition.
Animal models have provided experimental opportu-
nities for understanding what and how genetic conditions
contribute to the pathogenesis of human diseases. We
introduce a new mouse model with progressive joint disease
histopathologically resembling human ankylosing disorders.
Spontaneous joint disorders have been characterised in
several mouse models. Previous studies using these models
have delineated two distinct types of joint disease. One type is
classified as a synovitis-driven joint disease, which represents
histopathological and immunological features of human
rheumatoid arthritis.1–3 The other type is classified as an
enthesitis-driven joint disease. Recent studies have suggested
a close relationship between enthesitis-driven joint disease
and human ankylosing disorders, including spondyloarthro-
pathy and psoriatic arthropathy.4–7 In contrast with the
erosive manifestation of joint cartilage and bone in the
former type, proliferation and ossification in the entheseal
region are characteristic of the latter type. The pathogenic
mechanism in an enthesitis-driven joint disease has been
underscored in relation to the regeneration and ageing-
related change of joint as well as ankylosing disorders.
The present model spontaneously and stably develops an
enthesitis-driven joint disease in the ankle joints of the
particular F1 mice that are descended from a recently
established immunodeficient strain and a C3H/He.Faslpr
(C3H/lpr) strain. These two strains are defective in the
Fas gene function. The Fas gene encodes a receptor that
mediates the death signal in a variety of immune cells.
Therefore, a deleterious mutation of Fas causes a congenital
lymphoproliferative disorder in both humans and mice, in
which such lupus-like diseases conditionally present as
glomerulonephritis, systemic vasculitis, sialoadenitis and
arthritis. The immunodeficient strain used in this study
was recently isolated as a spontaneous mutant strain of MRL/
Mp.Faslpr, termed as MRL/rpl. We recently identified a loss-
of-function mutation on the signalling lymphocyte activation
molecule-associated protein (SAP) gene in the MRL/rpl strain
by positional cloning.8 Of particular interest, the regression of
autoimmune traits and lymphoproliferation is a characteristic
of MRL/rpl in the presence of the Faslpr mutation. SAP is a
signal adaptor protein for lymphocytic activation.9–12 A
germline defect of the SAP gene causes a human congenital
immune disorder, X-linked lymphoproliferative syndrome
(XLP).13 In patients with XLP and in SAP-deficient mice, it
was shown that the function of T cells14 15 and natural killer
cells16 17 and the development of natural killer T cells18 19 was
perturbed. As the present F1 male mice stably developed a
high grade of ankylosis under the SAP-deficient condition,
we questioned whether SAP regulated ankylosis onset.
The inheritance mode of ankylosis is a unique character-
istic in the present model. It was particularly noted that the
ankylosis developed in only (MRL/rpl6C3H/lpr; MC) F1 mice
but not in parental mice. A question arose of how genetic
factors controlled the onset of ankylosis in the F1 generation.
Abbreviations: DBA, dilute brown/non-agouti; FGFR2, fibroblast
growth factor receptor 2 gene; IFN, interferon; QTL, quantitative trait
locus; SAP, signalling lymphocyte activation molecule-associated
protein; XLP, X-linked lymphoproliferative syndrome
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In this report, we describe histopathological and genetic
characterisations of the new ankylosis model.
MATERIALS AND METHODS
Mice
C3H/lpr mice were purchased from The Jackson Laboratory
(Bar Harbor, Maine, USA) and bred under specific pathogen-
free conditions in the Animal Research Institute of the
Tohoku University Graduate School of Medicine, Sendai,
Japan. MRL/rpl, MCF1, (C3H/lpr6MRL/rpl; CM) F1 and MCF2
mice were housed in the same conditions. In all animal
experiments, we followed the Tohoku University guidelines
for animal experimentation.
Histopathological grading of ankylosis
All mice were killed at 6 months under ether anaesthesia for
tissue sampling. Foot joints were fixed with 10% formalin in
0.01 M phosphate buffer (pH 7.2), decalcified in 5% formic
acid containing 5% formalin and embedded in paraffin wax.
Tissue sections were stained with haematoxylin and eosin for
observations by light microscopy. Generally in the F1, and
especially in the F2 mice, a synovitis-driven lesion was
occasionally coincident with an enthesitis-driven lesion to
varied extents. To obtain a specific diagnosis for the
enthesitis-driven lesion, we adopted new histological criteria
as follows: no heterotopic cartilage and bone formation
(grade 0), slight heterotopic proliferation of cartilage or
fibrocartilage tissue (grade 1), a lesion similar to grade 1, but
severe (grade 2), and an advance of grade 2, associated with
joint dislocation and macroscopic swelling (grade 3). We
defined ankylosis grade of each mouse as the maximal grade
in six longitudinal sections prepared from bilateral hind
paws. A mouse with grade 1, 2 or 3 was considered to be a
positive case for ankylosis.
Mapping of ankylosis susceptibil ity loci
We bred the 257 MCF2 mice and determined their ankylosis
grades by microscopy examination. As the incidence of
ankylosis was evident only in the male group, we selected
48 male MCF2 mice, of which 24 were most severely affected
and 24 were unaffected. The selected 48 male MCF2 mice
were then subjected to a genomewide scan to estimate
ankylosis susceptibility loci with 71 polymorphic microsatel-
lite markers—namely, D1Mit276, D1Mit46, D1Mit494,
D1Mit115,D2Mit522, D2Mit37, D2Mit102, D2Mit448, D2Mit286,
D2Mit200, D3Mit224, D3Mit137, D3Mit101, D3Mit14, D4Mit89,
D4Mit15, D4Mit187, D4Mit147, D4Mit259, D5Mit145, D5Mit149,
D5Mit134, D5Mit23, D5Mit68, D5Mit33, D6Mit188, D6Mit15,
D7Mit76, D7Mit155, D7Mit230, D7Mit181, D7Mit126, D7Mit68,
D7Mit174, D8Mit65, D8Mit107, D9Mit217, D9Mit1001, D9Mit229,
D9Mit336, D9Mit182, D9Mit82, D10Mit95, D10Mit164,
D11Mit263, D11Mit334, D12Mit136, D12Mit4, D12Mit259,
D12Mit141, D13Mit60, D13Mit178, D13Mit202, D13Mit130,
D14Mit37, D14Mit39, D14Mit195, D15Mit20, D15Mit28,
D16Mit165, D16Mit57, D16Mit185, D17Mit264, D17Mit127,
D18Mit20, D18Mit51, D18Mit142, D19Mit60, D19Mit112,
DXMit140 and DXMit10. These markers provided coverage of
mouse genome with an average of 23.3 cM apart. As the
coverage for chromosome X with polymorphic markers was
insufficient, we determined genotypes of all male mice at
DXMit140 and DXMit10. After determining candidate chromo-
somes by the genomewide study (p,0.05), we analysed all
the samples to evaluate linkage loci. Polymerase chain
reactions were carried out under the following conditions:
94 C˚ for 2 min, 35 cycles of 94 C˚ for 30 s, 55 C˚ for 30 s 72 C˚
for 30 s, and a final extension at 72 C˚ for 5 min. The genetic
positions of microsatellite markers and genes were based on
the Mouse Genome Informatics provided by The Jackson
Laboratory.
Statistical analysis
In the association study, we used male MCF2 mice. An
association between ankylosis onset and genotype was
evaluated using the x2 test with standard 263 contingency
matrices. Estimation of significant or suggestive association
was based on p = 0.000052 or p = 0.0016, respectively, as
recommended by Lander and Kruglyak.20 Quantitative trait
locus (QTL) was determined with the 123 male mice.
Histopathological grades of ankylosis were used as the
indicators of phenotype. Logarithmic odd scores were
calculated by the interval mapping and composite interval
mapping methods in the Windows QTL Cartographer (V.2.5)
software developed by Zeng.21 We adopted the Model 6 with
forward and backward regression method for composite
interval mapping. The number of control markers, the
window size and the walk speed were set at 5, 10 and
2 cM, respectively. The statistically suggestive level (p = 0.05)
was determined with the permutation test (1000 times)
developed by Churchill and Doerge.22
RESULTS
Histopathological characterisation of the arthropathy
in the MCF1 mice
By 6 months, arthropathy was observed macroscopically as
swelling and rigidity of ankle in the male MCF1 group,
although not in the female MCF1 group (fig 1A,B). The
disease readily progressed from initial onset of maximal joint
swelling followed by irreversible ankle rigidity. The maximal
joint swelling was an acute incidence, although the swelling
continued to a lesser extent. Microscopically, pathological
changes were observed mainly in the ankle joints (fig 1C).
The arthropathy was characterised by fibroblast-like cell
proliferation with chondrocytic differentiation and ossifica-
tion at the region where joint capsule and ligaments attached
to bone (fig 1D,E). Periarticular enthesophytes and marginal
ankylosis were also evident (fig 1F). However, entheseal
tissue associated with Achilles tendon was barely affected.
Erosive change in cartilage and lymphocytic inflammation
were not common features. In a few cases, subcutaneous
acute inflammation with neutrophilic infiltration was
observed. Macroscopically, there was no evidence for the
involvement of interphalangeal joints. These findings suggest
that the arthropathy in MCF1 mice was similar to ankylosing
enthesitis as previously reported in some mouse strains.23 24
Incidence of the arthropathy
Table 1 summarises the incidence of microscopically defined
arthropathy. A mouse with ankylosis grade 1, 2 or 3 was
considered to be a positive case for ankylosis. It was found
that all male MCF1 mice developed ankylosis. In contrast,
female MCF1 mice scarcely developed it (19.4%, p,0.001 v
male). None of CMF1 mice developed ankylosis. It should be
particularly noted that ankylosis was not observed in the
parental strains, MRL/rpl and C3H/lpr. In the male MCF2
group, the incidence decreased (61.8%) as compared with the
male MCF1 group, but the histopathological feature of
ankylosis was similar to that in MCF1 mice. Male predomi-
nance of ankylosis onset was also evident in the MCF2 group
(p,0.001). During this study, we maintained every mouse in
a caged group of 3–7 mice. The caged group of mice was not
rearranged after weaning, as some previous studies have
done to facilitate ankylosis onset.5 6 In the MCF1 mice, we
found no significant difference in incidence of ankylosis
between the caged groups of (3 mice and >4 mice
(x2 = 2.06, p = 0.15).
Mapping of the ankylosis susceptibil ity loci
We first determined a candidate linkage locus based on
selective genome wide screening using the 48 male MCF2













Figure 1 Ankylosis in the ankle joints spontaneously developed in the MCF1 mice. (A) Unaffected ankle of the 6-month-old female MCF1 mouse. (B)
Affected ankle with remarkable swelling in the 6-month-old male MCF1 mouse. (C) Microscopic features of the advanced ankylosis lesion. The joint
fusion with ossified fibroblastic tissues. Haematoxylin and eosin (H&E) staining. Bar indicates 1 mm. (D) Fibroblast-like cell proliferation with
chondrocytic differentiation in the ligament (arrow). H&E staining. Bar indicates 100 mm. (E,F) Fibroblast-like cell proliferation with chondrocytic
differentiation (arrow in E) and ossification (arrowhead in E) in the ligaments. Periarticular enthesophyte (asterisk) and marginal ankylosis (double
asterisks) were commonly observed. H&E staining. Bars indicate 200 mm and 1 mm in (E) and (F), respectively. Cal, calcaneus; Cun, cuneiform bone;
Met, metatarsal bone; Nav, navicular bone; Tal, talus.
Table 1 Incidence and histopathological grades of ankylosis in MRL/rpl, C3H/lpr,
F1 and F2 mice
Strain, sex
Grades of ankylosis*
Incidence (%)0 1 2 3
MRL/rpl
Female 12 0 0 0 0
Male 16 0 0 0 0
Total 28 0 0 0 0
C3H/lpr
Female 6 0 0 0 0
Male 18 0 0 0 0
Total 24 0 0 0 0
MCF1
Female 25 6 0 0 19.4`
Male 0 5 15 19 100
Total 25 11 15 19 64.3
CMF1
Female 4 0 0 0 0
Male 9 0 0 0 0
Total 13 0 0 0 0
MCF2
Female 112 19 3 0 16.4`
Male 47 24 44 8 61.8`
Total 159 43 47 8 38.1
*Values represent the number of mice with the indicated ankylosis grade.
Incidence (%) = 100 6 (the number of total mice with grades 1, 2 and 3)/(the number of total mice).
`Significant difference between male and female, p,0.01, x2 test.
Genetic characterisation of a murine ankylosis model 1275
www.annrheumdis.com
mice, which consisted of 24 mice with grade 0 and 24 mice
with grade 2 or 3. The results suggested associations at a few
marker positions on chromosome 7, but not on any other
chromosome. We next determined genotypes of all male
MCF2 mice at D7Mit76, D7Mit155, D7Mit230, D7Mit181,
D7Mit126, D7Mit68 and D7Mit174, and evaluated the associa-
tion between the genotype of every marker position and onset
of ankylosis. The results confirmed linkages at D7Mit68 and
D7Mit174 (table 2). As markers’ coverage for chromosome X
was unsatisfactory, we determined genotypes of all the 122
male MCF2 mice at DXMit140 and DXMit10. There was no
association at these markers (table 2). Comparison of the
ankylosis grades between three genotype groups at D7Mit174
suggest that the linkage locus on chromosome 7 governed
ankylosis severity in a dominant susceptibility mode of
inheritance of the MRL allele (table 3).
In QTL analysis, interval mapping and composite interval
mapping showed linkage between D7Mit68 and D7Mit174,
where the threshold level (p = 0.05) of logarithmic odd scores
was determined by the permutation test (fig 2). A suggestive
interval was defined between 62 cM and the telomeric end of
chromosome 7, where fibroblast growth factor receptor 2
gene (FGFR2) and clustered interferon-inducible genes could
be highlighted as currently possible candidates for the
ankylosis susceptibility in the present model (reason dis-
cussed later).
DISCUSSION
It was shown that DBA (dilute brown/non-agouti)/1 mice
spontaneously developed ankylosing arthropathy in the foot
joints, resembling human spondylarthropathy or psoriatic
arthropathy.4 5 7 On the other hand, the incidences of another
class of ankylosing arthropathy, currently termed as ankylos-
ing enthesitis, was shown in some inbred strains of mice.23 24
Although these two classes were shown to be distinct in
preferentially affected sites and distribution of mice strains,
they were commonly characterised by ageing-dependent and
male-predominant ankylosis. Ankylosing enthesitis affected
ankle joints, whereas arthropathy in DBA/1 mice affected
more distal foot joints, including phalageal joints and the
toe region.25 26 Entheseal proliferation has been thought to be
a preceding feature of ankylosis in those models. Bone
erosion and lymphocytic inflammation were not their main
representation, which is in contrast to the models established
as rheumatoid arthritis. The present MCF1 model shares
pathological characteristic with the previously defined
ankylosing models, including male predominance and
entheseal involvement without bone erosion.
It was of particular interest how the unique inheritance
mode of disease was genetically interpreted in the present
model. The high incidence at the F1 generation posed an
insight into a strong genetic contribution in ankylosis onset.
On completing the present genetic study, we identified only a
single autosomal dominant susceptibility locus on chromo-
some 7. Our findings from reciprocal breeding of MRL/rpl and
C3H/lpr suggested an implication of the Y chromosome of the
C3H/lpr mice in ankylosis onset. Although we presently
cannot rule out sum effects of minor loci, the present findings
may allow us to interpret the F1 onset mode and male
predominance with the additive effect of the autosomal
dominant locus and a Y-linked locus. This inheritance
mechanism may in part interpret a sporadic mode of disease
transmission in human.
Oishi et al27 reported the spontaneous occurrence of
ankylosis in (MRL 6 DBA/1; MD) F1 mice. Similar to the
present model, their study on ankylosis was characterised by
entheseal involvement in male-predominant manner.
However, the incidence of ankylosis in male MDF1 mice
(29.4%) was much lower than that in the present model,
suggesting a role for lpr mutation or particular C3H-derived
factors in acceleration of ankylosis onset. The genetic study
using MDF2 mice suggested four autosomal susceptibility loci
to the severity or onset of ankylosis, none of which
overlapped with our locus. In addition, the incidences of
ankylosis were seen equally in two reciprocally mating
groups, MDF1 and (DBA/16MRL) F1, indicating no associa-
tion of the Y chromosome with ankylosis onset in MDF1
mice. This example is different from our case. Male
predominance in the present model may not simply be
interpreted by a Y-linked locus.
The locus identified in this study, the telomeric region of
chromosome 7, includes many positional candidates for the
susceptibility gene to ankylosis onset. Of them, we first
evaluate a candidacy of the FGFR2 gene. The FGFR2 protein
comprises three immunoglobulin-like domains in the extra-
cellular region, a single membrane-spanning segment and a
cytoplasmic tyrosine kinase domain. Currently accumulating
evidence has shown that a mutation on FGFR2 causes several
human congenital disorders, including Crouzon syndrome,28
Jackson–Weiss syndrome,29 Apert syndrome30 and Pfeiffer
syndrome.31 32 These disorders are characterised by patholo-
gical bone fusion of craniofacial region or limbs.








MM MC CC MM MC CC
Chromosome 7
D7Mit76 3.4 10 23 7 14 49 19 1.29 0.53
D7Mit155 15 10 22 8 17 47 18 0.29 0.86
D7Mit230 24.5 7 25 8 15 46 21 0.55 0.76
D7Mit181 37 6 19 15 23 36 23 2.77 0.25
D7Mit126 50 6 15 19 27 36 19 8.57 0.014
D7Mit68 60 6 15 19 25 43 14 13.00 0.002
D7Mit174 69 8 15 17 23 49 10 14.38 0.008
Chromosome X
DXMit140 19 23 0 17 52 0 30 0.40 0.53
DXMit10 63.2 14 1 22 45 4 28 5.44 0.066
MM, MC and CC genotypes indicate MRL/MRL homozygote, MRL/C3H heterozygote and C3h/C3H homozygote,
respectively.
*x2 values for the chromosome 7 or X markers were determined by the x2 test with 263 or 262 contingency
matrices, respectively.
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Interestingly, the transgenic mice with a gain-of-function
mutation on FGFR2 showed skeletal abnormalities associated
with a premature fusion of cranial sutures and multiple joint
fusions, which were considered to be similar to the
phenotypes of some cases of Apert or Pfeiffer syndromes.33 34
They confirmed not only the link between a gain-of-function
mutation on FGFR2 and the human congenital disorders but
also the role of FGFR2 in endochondral bone formation. It
may be possible that an unidentified FGFR2 polymorphism
leads to chondrocyte proliferation in the entheseal region of
the present model. In addition, a gene family consisting of
interferon (IFN)-inducible transmembrane proteins could be
considered to be a reasonable candidate, because the previous
study showed the mandatory role of IFNc in the spontaneous
occurrence of ankylosis in DBA/1 mice.35 It would be
particularly interesting to study whether those candidate
genes are polymorphic between the two strains used in this
study.
We initially observed ankylosis onset in the MCF1 mice,
which were descended from the SAP-deficient female MRL/
rpl mice and male C3H/lpr mice. All the male MCF1 mice
became SAP deficient, because the SAP is an X-linked gene.
Therefore, we hypothesised a suppressive role of SAP in
ankylosis onset. But no linkage was proved between
ankylosis onset and DXMit140, which is located very close
to the SAP gene. This fact clearly shows that SAP deficiency is
not associated with ankylosis onset. Previous studies have
shown that SAP deficiency in mice and humans causes severe
perturbation of the development of natural killer T cells.
Taken together with the findings were, the ankylosis in the
present model seems to occur independently of natural killer
T cell contribution. Previous studies have shown that T cells
are dispensable7 but IFNc is indispensable for the develop-
ment of entheseal ossification in DBA/1 mice.35 Now T cell-
independent and IFNc-dependent mechanisms may be
underscored in mouse ankylosis models.
To date, careful observations have shown increased
evidence of ankylosis-related arthropathy in the rodent
species. Most cases are evident without any specified
mutation in male-specific manner. This fact may pose an
insight that incidence of ankylosis is dominated by both
common genetic factors and male-specific condition. Our
high-incidence model will provide an opportunity for further
understanding the genetic mechanisms of ankylosing joint
disorders.
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